Southwest Airlines Co vs State Street SPDR S&P Biotech ETF — how do they compare? Southwest Airlines Co trades at $48.76 (market cap $23.63B), while State Street SPDR S&P Biotech ETF trades at $153.92. The key difference: Southwest Airlines Co pays a 1.49% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Southwest Airlines Co nearer its low. Which is the better fit depends on your goals.
| LUV | XBI | |
|---|---|---|
Market Cap | $23.63B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $54.80 | $164.28 |
52-Week Low | $29.06 | $85.16 |
Enterprise Value | $26.70B | — |
Dividend Yield | 1.49% | — |
Signals from Pluang's Aura AI — not financial advice
Southwest Airlines (LUV) trades at $48.28, up 0.42% today, with a neutral technical signal and mixed earnings history. Recent Q1 2026 EPS missed expectations, but Q4 2025 and Q3 2025 beat. Financials show modest revenue growth to $28.06B in 2025, but net income margin is thin at 2.83%. Analyst consensus is mixed with 42% buy, 47% hold, and 11% sell ratings, and a $52.47 price target implies potential upside. Key news highlights Q2 2026 earnings due July 23, 2026, amid fuel cost volatility and travel demand resilience.
LUV presents a cautious opportunity with upside to the consensus target, supported by operational improvements and sector tailwinds, but risks from fuel price swings, execution challenges, and thin margins warrant careful monitoring. The stock's valuation at a P/E of 32.05 appears elevated relative to earnings growth, requiring strong future performance to justify current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →